Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Treatment for Neurosensory Recovery After BSSO
NCT05536596Phase 3Unknown
- Sponsor
- Universitat Internacional de Catalunya
- Start
- Sep 2022
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of uridine triphosphate, cytidine monophosphate, hydroxocobalamin, melatonin in peripheral nerve injury (PNI), sponsored by Universitat Internacional de Catalunya. Status: unknown.
02
Drugs
uridine triphosphatecytidine monophosphatehydroxocobalaminmelatonin
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT05536596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05536596.